In deed, malignant ascites is known to protect human ovarian cancer cells from TRAIL-induced apoptosis through αvβ5 integrin-mediated focal adhesion kinase/Akt activation and ERK1/2-Elk-1 signaling [17, 18]. This evidence concerns the gene ELK1 and ovarian carcinoma.